In 1943, a chemist in Switzerland synthesized a drug that alters consciousness. His discovery changed the study of medicine, ...

Definium Therapeutics is expecting late-stage data for two anxiety trials in the coming months, teeing up a potential ...

A new policy shift could open the door to clinical use of drugs like psilocybin and MDMA, but legal and safety questions ...

Researchers from McGill University and Mila, Quebec’s artificial intelligence institute, brought together 89 experts from 17 ...

Drug trials generally involve comparing a treatment with a nonactive, placebo version, an approach called "blinding" because ...

An upcoming executive order is intended to accelerate research into the compounds’ efficacy in treating PTSD, depression and ...

A new study suggests that four psychoactive compounds work in surprisingly similar ways, and that they break down the ...

Psychedelic treatments, such as LSD and psilocybin, have been hailed as breakthrough options for depression. However, new ...

Founders of the Integrative Psychiatry Institute, Dr. Will Van Derveer and Keith Kurlander, discuss their new book, Psychedelic Therapy: A Revolutionary Approach to Restoring Mental Health and ...

UCSF research shows psychedelics like psilocybin may treat depression, Parkinson’s, and addiction, offering new hope in ...

To honor that history, Zide Door is marking the 4/20 event with special offerings for members starting April 17 through April 20. To celebrate the four-day period, the church will grant free ...